S Korea to approve world`s 1st stem cell drug
Seoul: South Korea`s drug safety agency will likely approve a stem cell therapeutic drug early next month in what could be the world`s first move to permit the sale of a stem-cell medicine, officials said today.
The Korea Food and Drug Administration (KFDA) is expected to finalise all procedures needed to permit the sale of "Hearticellgram-AMI," a stem cell therapy for acute myocardial infarction, on July 1, according to the KFDA officials.
The therapy was developed by FCB-Pharmicell, which specialises in developing stem cell drugs for incurable diseases.
The drug has passed all three procedures, including safety and validity tests, needed for its approval. The other remaining steps will likely be completed soon, the officials said.
Hearticellgram-AMI takes somatic stem cells extracted from the patient`s own body that are then cultured and directly injected into his or her damaged heart.
comments powered by Disqus
- Pak envoy shows fake photo to defame India at UN
- Doklam standoff: China deploys over 12,000 troops in Chumbi Valley
- Pak's nuclear weapons at risk of being stolen by terrorists: US scientists
- Govt failed to fulfill any of its promises in 3 years of reign: Mulayam Singh
- TMC MP Mukul Roy to quit party post Durga Puja
- Newton for Oscars: Priyanka Chopra and mother Madhu Chopra upset over film's entry?
- Mahira Khan and Ranbir Kapoor NYC photo frenzy: Bollywood stands up in defence
- 41-year-old woman detained at passport control for being 'too young'
- Eman Ahmed, once dubbed as world's heaviest woman, passes away
- This Twitter convo between Kumar Sangakkara and Hardik Pandya is pure gold